Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Which Health-Related Quality of Life Items Most Affect Acne Patients?
Chernyshov PV, Sampogna F, Zouboulis CC, Boffa MJ, Marron SE, Manolache L, Pustišek N, Bettoli V, Koumaki D, Chubar O, Pochynok TV, Mintoff D, Bonitsis NG, Spillekom-van Koulil S, Driessen RJB, Chernyshov AV, Bewley AP, Evers AWM, Chernyshov IP, Tomas-Aragones L. Chernyshov PV, et al. Among authors: bewley ap. Dermatology. 2023;239(2):267-272. doi: 10.1159/000526602. Epub 2022 Dec 7. Dermatology. 2023. PMID: 36476839
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Thyssen JP, Bewley A, Ständer S, Castro C, Misery L, Kim BS, Biswas P, Chan G, Myers DE, Watkins M, Alderfer J, Güler E, Silverberg JI. Thyssen JP, et al. Dermatology. 2024;240(2):243-253. doi: 10.1159/000535285. Epub 2023 Dec 11. Dermatology. 2024. PMID: 38081155 Free PMC article. Clinical Trial.
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
Paller AS, Flohr C, Cork M, Bewley A, Blauvelt A, Hong HC, Imafuku S, Schuttelaar MLA, Simpson EL, Soong W, Arlert P, Lophaven KW, Kurbasic A, Soldbro L, Vest NS, Wollenberg A. Paller AS, et al. JAMA Dermatol. 2023 Jun 1;159(6):596-605. doi: 10.1001/jamadermatol.2023.0627. JAMA Dermatol. 2023. PMID: 37074705 Free PMC article. Clinical Trial.
Damaging Alleles Affecting Multiple CARD14 Domains Are Associated with Palmoplantar Pustulosis.
Niaouris A, Hernández-Cordero A, Haddad S, Hassi NK, Benzian-Olsson N, Bugarin Diz C, Burden AD, Cooper HL, Griffiths CEM, Parslew R, Pink AE, Reynolds NJ, Wahie S, Warren RB, Wright A, Simpson M, Baum P, Visvanathan S, Barker JN, Smith CH, Capon F; APRICOT and PLUM study team. Niaouris A, et al. J Invest Dermatol. 2023 Mar;143(3):504-508.e5. doi: 10.1016/j.jid.2022.07.031. Epub 2022 Sep 27. J Invest Dermatol. 2023. PMID: 36174714 Free article. No abstract available.
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis.
Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA, Barker JN, Dand N, Smith CH; BADBIR; BSTOP Study Groups. Douroudis K, et al. J Invest Dermatol. 2022 Jun;142(6):1617-1628.e10. doi: 10.1016/j.jid.2021.08.446. Epub 2021 Nov 10. J Invest Dermatol. 2022. PMID: 34767815 Free article.
Development of the acne-specific quality of life questionnaire Quality of Life Relevance-Acne.
Chernyshov PV, Sampogna F, Raimondi G, Zouboulis CC, Boffa MJ, Marron SE, Manolache L, Pustišek N, Bettoli V, Koumaki D, Bewley AP, Dreno B, Tomas-Aragones L. Chernyshov PV, et al. Among authors: bewley ap. JAAD Int. 2024 Mar 25;16:9-17. doi: 10.1016/j.jdin.2024.03.007. eCollection 2024 Sep. JAAD Int. 2024. PMID: 38764481 Free PMC article.
58 results